Clin2
NCT07841535Worth exploringRecruiting

Faster germ detection in sepsis patients at an Indonesian hospital

SepsisAntimicrobial Resistance (AMR)

Part of Infections clinical trials.

This study compares different laboratory methods to find the exact germs causing your sepsis more quickly and accurately. Faster identification could mean better targeted treatment, potentially improving your recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
415 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You have sepsis or septic shock with organ dysfunction.
  • You are hospitalized at RSCM and have had blood cultures or other microbiology tests.
  • You have at least one risk factor for multidrug-resistant (MDR) germs, like a past resistant infection, long antibiotic use, or a long ICU stay.
  • You have not received IV antibiotics for more than 24 hours for this current infection before joining.
  • You must agree to provide samples and sign a consent form (or have a legal representative sign).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07843277Recruiting
Improving sepsis care in Indonesian emergency rooms

This study tests whether a special medical chart helps doctors spot sepsis earlier and reduce deaths in Indonesian hospitals. If you or your loved one are diagnosed with sepsis in the emergency department, this could improve care and outcomes.

Jakarta Pusat, DKI Jakarta
NCT07580001Not yet recruiting
Faster infection testing for ICU patients with sepsis

This trial tests a new rapid test that can quickly identify the cause of a severe infection (sepsis) in ICU patients. The goal is to see if faster results help doctors choose the right treatment sooner.

Shanghai
NCT07813767Recruiting· Phase 3
Early antibiotic treatment guided by a blood test to prevent severe infection

This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.

Athens, Attica
NCT01904188Recruiting
Rapid identification of infection germs and antibiotic resistance

This study tests whether a faster lab method can correctly identify the germ causing an infection and check which antibiotics may work, using samples taken in the emergency department. It may help doctors choose the right treatment sooner for people with serious suspected infection.

Lansing, Michigan
NCT07817043Not yet recruiting
Sepsis blood culture testing study

This study looks at how labs process blood cultures for sepsis to find faster, better ways to detect infections. It may help improve treatment speed for patients with sepsis.

Greifswald
NCT06103500Recruiting
Helping choose the right antibiotic for sepsis

This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.

Mississauga, Ontario

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.